Myomo Inc MYO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MYO is a good fit for your portfolio.
News
-
Myomo Appoints Heather Getz to its Board of Directors
-
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
-
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®
-
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
-
Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
-
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
-
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
Trading Information
- Previous Close Price
- $2.70
- Day Range
- $2.63–2.82
- 52-Week Range
- $0.41–5.55
- Bid/Ask
- $2.76 / $2.85
- Market Cap
- $80.33 Mil
- Volume/Avg
- 125,452 / 329,905
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.74
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 106
- Website
- https://www.myomo.com
Valuation
|
Metric
|
MYO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 9.33 |
Price/Sales | 4.74 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MYO
|
|---|---|
Quick Ratio | 2.05 |
Current Ratio | 2.49 |
Interest Coverage | — |
Quick Ratio
MYO
Profitability
|
Metric
|
MYO
|
|---|---|
Return on Assets (Normalized) | −52.62% |
Return on Equity (Normalized) | −80.80% |
Return on Invested Capital (Normalized) | −79.74% |
Return on Assets
MYO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ykxyzst | Vgynjpd | $188.9 Bil | |
SYK
| Stryker Corp | Ttqlbngr | Jsntl | $129.0 Bil | |
MDT
| Medtronic PLC | Hmbrsfdm | Dyhlc | $106.5 Bil | |
BSX
| Boston Scientific Corp | Lxsdbdp | Mgzpvyy | $100.9 Bil | |
EW
| Edwards Lifesciences Corp | Qkfycdzw | Mylqmt | $53.7 Bil | |
DXCM
| DexCom Inc | Lwdlhrnpm | Rqppm | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qqwvxjbkp | Kpxh | $25.5 Bil | |
ALGN
| Align Technology Inc | Njxkvfn | Plrzv | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Ybzfdmzkv | Nmzzdn | $18.7 Bil | |
PODD
| Insulet Corp | Kxxtybtkgq | Vyzvpnm | $12.3 Bil |